AKT1 and non-small cell lung carcinoma: Additionally, the lncRNA actin filament-associated protein 1 antisense RNA 1 (AFAP1-AS1) activates AKT signalling by upregulating RRM2 and subsequently promotes CDDP resistance in non-small cell lung cancer (NSCLC) [14].